UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EORTC elderly task force position paper: Approach to the older cancer patient

European journal of cancer (1990), 2010-06, Vol.46 (9), p.1502-1513

2010

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80 (2), p.120-130

2013

Volltextzugriff (PDF)

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderly population

Annals of oncology, 2010-04, Vol.21 (4), p.692-706

2010

Volltextzugriff (PDF)

Questionnaires and instruments for a multidimensional assessment of the older cancer patient: What clinicians need to know?

European journal of cancer (1990), 2010-04, Vol.46 (6), p.1019-1025

2010

Volltextzugriff (PDF)

Targeted therapies in the treatment of advanced/metastatic NSCLC

European journal of cancer (1990), 2009-09, Vol.45 (14), p.2473-2487

2009

Volltextzugriff (PDF)

EORTC Elderly Task Force experts’ opinion for the treatment of colon cancer in older patients

Cancer treatment reviews, 2010-02, Vol.36 (1), p.83-90

2010

Volltextzugriff (PDF)

Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?

Cancer treatment reviews, 2010-08, Vol.36 (5), p.436-441

2010

Volltextzugriff (PDF)

Are we treating enough elderly patients with early stage non-small cell lung cancer?

Lung cancer (Amsterdam, Netherlands), 2011-11, Vol.74 (2), p.149-154

2011

Volltextzugriff (PDF)

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy

Lung cancer (Amsterdam, Netherlands), 2008-12, Vol.62 (3), p.356-363

2008

Volltextzugriff (PDF)

Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology

Annals of oncology, 2014-07, Vol.25 (7), p.1270-1283

2014

Volltextzugriff (PDF)

EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors

Annals of oncology, 2011-08, Vol.22 (8), p.1922-1926

2011

Volltextzugriff (PDF)

Carboplatin plus gemcitabine as first-line treatment in eldelry patients with non-small-cell lung cancer: Preliminary results of a multicenter phase ii trial by the Hellenic Oncology Researsch Group (HORG)

Journal of geriatric oncology, 2013-10, Vol.4, p.S40-S40

2013

Volltextzugriff (PDF)

A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer

Annals of oncology, 2012-05, Vol.23 (5), p.1164-1169

2012

Volltextzugriff (PDF)

Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: A multicenter phase II trial

Lung cancer (Amsterdam, Netherlands), 2007-01, Vol.55 (1), p.101-107

2007

Volltextzugriff (PDF)

A phase II study of the combination of bevacizumab with cytotoxic chemotherapy, as first line treatment, in older patients with advanced/metastatic NSCLC (non-squamous)

Journal of geriatric oncology, 2012-10, Vol.3, p.S69-S69

2012

Volltextzugriff (PDF)

Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group

Annals of oncology, 2011-11, Vol.22 (11), p.2448-2455

2011

Volltextzugriff (PDF)

Biweekly carboplatin plus gemcitabine as first-line treatment of elderly patients with advanced squamous non-small-cell lung cancer: A multicenter phase I-II trial by the Hellenic Oncology Research Group

Clinical lung cancer, 2016-11, Vol.17 (6), p.543-549

2016

Volltextzugriff (PDF)

Economic evaluation of docetaxel–gemcitabine versus vinorelbine–cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis

Annals of oncology, 2010-07, Vol.21 (7), p.1462-1467

2010

Volltextzugriff (PDF)

Adjuvant Chemotherapy for Colon Cancer

Anticancer research, 2006-11, Vol.26 (6C), p.4809-4815

2006

Volltextzugriff (PDF)

Instruments for Quality of Life Assessment in Patients with Gastrointestinal Cancer

Anticancer research, 2004-05, Vol.24 (3B), p.2117-2121

2004

Volltextzugriff (PDF)

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program

Lung cancer (Amsterdam, Netherlands), 2003-06, Vol.40 (3), p.301-307

2003

Volltextzugriff (PDF)

Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis

Lung cancer (Auckland), 2012-01, Vol.3 (default), p.43-51

2012

Volltextzugriff (PDF)

Instruments for quality of life assessment in patients with inflammatory bowel disease

Digestive and liver disease, 2000-11, Vol.32 (8), p.682-688

2000

Volltextzugriff (PDF)

Autonomic imbalance during the day in patients with inflammatory bowel disease in remission. Evidence from spectral analysis of heart rate variability over 24 hours

Digestive and liver disease, 2002-11, Vol.34 (11), p.775-780

2002

Volltextzugriff (PDF)

Quality of Life of Greek Patients with Inflammatory Bowel Disease

Digestion, 2001-04, Vol.63 (4), p.240-246

2001

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

EORTC elderly task force position paper: Approach to the older cancer patient

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderly population

Questionnaires and instruments for a multidimensional assessment of the older cancer patient: What clinicians need to know?

Targeted therapies in the treatment of advanced/metastatic NSCLC

EORTC Elderly Task Force experts’ opinion for the treatment of colon cancer in older patients

Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?

Are we treating enough elderly patients with early stage non-small cell lung cancer?

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy

Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology

EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors

Carboplatin plus gemcitabine as first-line treatment in eldelry patients with non-small-cell lung cancer: Preliminary results of a multicenter phase ii trial by the Hellenic Oncology Researsch Group (HORG)

A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer

Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: A multicenter phase II trial

A phase II study of the combination of bevacizumab with cytotoxic chemotherapy, as first line treatment, in older patients with advanced/metastatic NSCLC (non-squamous)

Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group

Biweekly carboplatin plus gemcitabine as first-line treatment of elderly patients with advanced squamous non-small-cell lung cancer: A multicenter phase I-II trial by the Hellenic Oncology Research Group

Economic evaluation of docetaxel–gemcitabine versus vinorelbine–cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis

Adjuvant Chemotherapy for Colon Cancer

Instruments for Quality of Life Assessment in Patients with Gastrointestinal Cancer

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program

Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis

Instruments for quality of life assessment in patients with inflammatory bowel disease

Autonomic imbalance during the day in patients with inflammatory bowel disease in remission. Evidence from spectral analysis of heart rate variability over 24 hours

Quality of Life of Greek Patients with Inflammatory Bowel Disease

Suchergebnisse filtern